Equillium, Inc. (EQ)
2.23
-0.02
(-0.89%)
USD |
NASDAQ |
Sep 03, 10:51
Equillium Cash from Investing (Quarterly) : -0.071M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.071M |
| March 31, 2026 | -0.003M |
| December 31, 2025 | -0.032M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 4.496M |
| December 31, 2024 | 5.996M |
| September 30, 2024 | 12.00M |
| June 30, 2024 | -1.351M |
| March 31, 2024 | -2.831M |
| December 31, 2023 | -5.566M |
| September 30, 2023 | 10.98M |
| June 30, 2023 | 15.00M |
| March 31, 2023 | -25.18M |
| December 31, 2022 | 6.978M |
| September 30, 2022 | 15.00M |
| June 30, 2022 | 8.691M |
| Date | Value |
|---|---|
| March 31, 2022 | -11.98M |
| December 31, 2021 | -16.89M |
| September 30, 2021 | 10.47M |
| June 30, 2021 | 28.97M |
| March 31, 2021 | 4.86M |
| December 31, 2020 | -17.04M |
| September 30, 2020 | -23.02M |
| June 30, 2020 | 8.455M |
| March 31, 2020 | 13.00M |
| December 31, 2019 | -5.33M |
| September 30, 2019 | -0.225M |
| June 30, 2019 | 6.04M |
| March 31, 2019 | -2.651M |
| December 31, 2018 | -37.41M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -0.005M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Fortress Biotech, Inc. | -0.079M |
| Cue Biopharma, Inc. | 0.00 |
| Legend Biotech Corp. | -120.10M |
| Dianthus Therapeutics, Inc. | -478.52M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.107M |
| Cash from Financing (Quarterly) | 0.042M |
| Free Cash Flow | -20.09M |
| Free Cash Flow Per Share (Quarterly) | -0.0374 |
| Free Cash Flow to Equity (Quarterly) | -4.07M |
| Free Cash Flow to Firm (Quarterly) | -4.178M |
| Free Cash Flow Yield | -9.87% |